AI, Clinical Trials, and Digital Therapeutics for the undergrad science journal

I was recently accepted to Columbia Undergraduate Science Journal (CUSJ)’s Summer Publishing Program, where I researched and wrote two articles. Check them out :)

Beyond Drug Prescriptions: The Promise and Reality of Prescription Digital Therapeutics
journals.library.columbia.edu/index.php/cusj/blog/view/242

A review of the fledgling digital therapeutic market and whether it has the potential to replace traditional medications.

The Future of Clinical Trials
[link coming]

Clinical trials are a major hold-up in the drug development pipeline for pharmaceutical companies, with only ~10% of drugs able to move past it. But only half of all clinical trials fail because the drug itself doesn't work. The other half fails because of errors related to the trial itself—errors that jeopardise investments into not only the trial itself but also the drug development and research that come before it. Digital integration and artificial intelligence can help.